Low c-Met expression levels are prognostic for and predict the benefits of temozolomide chemotherapy in malignant gliomas

Aberrant c-Met has been implicated in the development of many cancers. The objective of this study was to identify an unfavorable prognostic marker that might guide decisions regarding clinical treatment strategies for high-grade gliomas. C-Met expression was measured using immunohistochemistry in 7...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ming-Yang, Yang, Pei, Liu, Yan-Wei, Zhang, Chuan-Bao, Wang, Kuan-Yu, Wang, Yin-Yan, Yao, Kun, Zhang, Wei, Qiu, Xiao-Guang, Li, Wen-Bin, Peng, Xiao-Xia, Wang, Yong-Zhi, Jiang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754763/
https://www.ncbi.nlm.nih.gov/pubmed/26879272
http://dx.doi.org/10.1038/srep21141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754763/
https://www.ncbi.nlm.nih.gov/pubmed/26879272
http://dx.doi.org/10.1038/srep21141

Ejemplares similares